Jiangsu Nanfang Medical (603880) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Jiangsu Nanfang Medical (603880) has a cash flow conversion efficiency ratio of 0.048x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥12.53 Million ≈ $1.83 Million USD) by net assets (CN¥259.57 Million ≈ $37.98 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Jiangsu Nanfang Medical - Cash Flow Conversion Efficiency Trend (2012–2024)
This chart illustrates how Jiangsu Nanfang Medical's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read 603880 current and long-term liabilities for a breakdown of total debt and financial obligations.
Jiangsu Nanfang Medical Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Jiangsu Nanfang Medical ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
BIG TECHNOLOGIES LS-10
F:7I8
|
N/A |
|
Churchill Capital Corp IX
NASDAQ:CCIX
|
-0.001x |
|
Nanning Sugar Industry Co Ltd
SHE:000911
|
0.920x |
|
Gersan Elektrik Ticaret ve Sanayi AS
IS:GEREL
|
-0.369x |
|
Avalo Therapeutics Inc
NASDAQ:AVTX
|
-0.179x |
|
Orion Engineered Carbons SA
F:0OE
|
0.171x |
|
Tufton Oceanic Assets Ltd
LSE:SHIP
|
0.036x |
|
Kung Long Batteries Industrial Co Ltd
TW:1537
|
0.106x |
Annual Cash Flow Conversion Efficiency for Jiangsu Nanfang Medical (2012–2024)
The table below shows the annual cash flow conversion efficiency of Jiangsu Nanfang Medical from 2012 to 2024. For the full company profile with market capitalisation and key ratios, see Jiangsu Nanfang Medical market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥284.41 Million ≈ $41.62 Million |
CN¥63.32 Million ≈ $9.27 Million |
0.223x | +580.74% |
| 2023-12-31 | CN¥474.22 Million ≈ $69.39 Million |
CN¥15.51 Million ≈ $2.27 Million |
0.033x | -35.01% |
| 2022-12-31 | CN¥621.48 Million ≈ $90.94 Million |
CN¥31.28 Million ≈ $4.58 Million |
0.050x | +139.12% |
| 2021-12-31 | CN¥654.90 Million ≈ $95.83 Million |
CN¥-84.25 Million ≈ $-12.33 Million |
-0.129x | -158.50% |
| 2020-12-31 | CN¥700.80 Million ≈ $102.55 Million |
CN¥154.12 Million ≈ $22.55 Million |
0.220x | +278.28% |
| 2019-12-31 | CN¥567.52 Million ≈ $83.05 Million |
CN¥32.99 Million ≈ $4.83 Million |
0.058x | -38.28% |
| 2018-12-31 | CN¥560.04 Million ≈ $81.95 Million |
CN¥52.75 Million ≈ $7.72 Million |
0.094x | +2.84% |
| 2017-12-31 | CN¥537.57 Million ≈ $78.66 Million |
CN¥49.24 Million ≈ $7.20 Million |
0.092x | -76.34% |
| 2016-12-31 | CN¥256.69 Million ≈ $37.56 Million |
CN¥99.35 Million ≈ $14.54 Million |
0.387x | -5.01% |
| 2015-12-31 | CN¥222.51 Million ≈ $32.56 Million |
CN¥90.66 Million ≈ $13.27 Million |
0.407x | +16.89% |
| 2014-12-31 | CN¥210.90 Million ≈ $30.86 Million |
CN¥73.52 Million ≈ $10.76 Million |
0.349x | +191.73% |
| 2013-12-31 | CN¥168.57 Million ≈ $24.67 Million |
CN¥20.14 Million ≈ $2.95 Million |
0.119x | -80.93% |
| 2012-12-31 | CN¥121.38 Million ≈ $17.76 Million |
CN¥76.07 Million ≈ $11.13 Million |
0.627x | -- |
About Jiangsu Nanfang Medical
Jiangsu Nanfang Medical Co., Ltd. engages in the research and development, production, and sale of transdermal, medical proof fabrics, adhesive tapes and bandages, sports protection, first-aid kits, and care products in China and internationally. It offers medical wound dressings, capsicum plasters, physical therapy tapes, pain relief sleeves, rigid sports tapes, wound plaster dressings, medical … Read more